Humanized Exposures of Cefiderocol, a Siderophore Cephalosporin, Display Sustained in vivo Activity against Siderophore-Resistant Pseudomonas aeruginosa
Open Access
- 22 February 2018
- journal article
- research article
- Published by S. Karger AG in Pharmacology
- Vol. 101 (5-6) , 278-284
Abstract
We evaluated the in vivo efficacy of humanized exposures of cefiderocol, a novel siderophore cephalosporin, against a test panel of P. aeruginosa (PSA) previously shown to develop resistance to 2 preclinical candidate siderophores (MB-1 and SMC-3176). In the thigh infection model, the PSA bacterial density in untreated controls grew from 5.54 ± 0.23 to 8.68 ± 0.57 log10 CFU over 24 h. The humanized cefiderocol exposure resulted in >1 log10 CFU reduction in all 8 isolates, while MB-1 and SMC-3176 exhibited variable activity similar to that previously reported. Humanized exposures of cefepime and levofloxacin, acting as positive antimicrobial controls displayed activity consistent with that of the bacterial phenotypic susceptibility profiles. Cefiderocol manifested in vivo efficacy against all PSA isolates including those resistant to cefepime and levofloxacin in contrast to its predecessor siderophore compounds. These preclinical data are supportive of further evaluation of cefiderocol in the treatment of P. aeruginosa.Keywords
This publication has 21 references indexed in Scilit:
- Understanding the mechanisms and drivers of antimicrobial resistanceThe Lancet, 2016
- In Vivo Activities of Simulated Human Doses of Cefepime and Cefepime-AAI101 against Multidrug-Resistant Gram-Negative EnterobacteriaceaeAntimicrobial Agents and Chemotherapy, 2015
- Potentiation of Antibacterial Activity of the MB-1 Siderophore-Monobactam Conjugate Using an Efflux Pump InhibitorAntimicrobial Agents and Chemotherapy, 2015
- Utilization of microbial iron assimilation processes for the development of new antibiotics and inspiration for the design of new anticancer agentsBioMetals, 2009
- Iron Metabolism and InfectionFood and Nutrition Bulletin, 2007
- Pharmacokinetics of Intravenous and Oral Levofloxacin in Critically Ill Adults in a Medical Intensive Care UnitPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2002
- A reverse-phase, isocratic high-performance liquid chromatography assay for levofloxacinJournal of Antimicrobial Chemotherapy, 1999
- The bacterial outer membrane as a drug barrierTrends in Microbiology, 1997
- High-pressure liquid chromatographic analysis of BMY-28142 in plasma and urineAntimicrobial Agents and Chemotherapy, 1987
- IRON ABSORPTION AND TRANSPORT IN MICROORGANISMSAnnual Review of Nutrition, 1981